those group 1 patients ( group 1a ) with increased ventricular ectopic activity ( vea ) during hctz therapy were subsequently potassium-repleted with amiloride and with supplemental potassium chloride to evaluate the effect of these treatments on vea .
C0032821
potassium
C0002502
amiloride